This is a Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients With Multiple Myeloma

This study is ongoing, but not recruiting participants.

Study NCT00639002 Information provided by Incyte Corporation

First Received: March 12, 2008 Last Updated: January 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)